Deals, Dupixent and GLP-1 drug shortages

from BioSpace · host BioSpace

This week we talk struggles with GLP-1 drug shortages and what that might mean for Novo/Lilly competitors; Regeneron and Sanofi positive results for ⁠⁠Dupixent⁠⁠ in COPD. Plus, Merck buys Caraway, Beigene's deal with Ensem, ups and downs for Flagship. Join BioSpace's Lori Ellis, Greg Slabodkin and Tyler Patchen as they discuss the most important biopharma news this week.

Episode metadata supplied by the publisher feed · Published Nov 29, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Deals, Dupixent and GLP-1 drug shortages

0:00 17:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioSpace?

This episode is 17 minutes long.

When was this BioSpace episode published?

This episode was published on November 29, 2023.

Can I download this BioSpace episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!